Novavax announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to provide 1.1 billion doses of the company’s Covid-19 vaccine candidate NVX-CoV2373 for the COVAX Facility.
The two Covid-19 vaccines approved for use in the United States have reassuring safety profiles, the U.S. Centers for Disease Control and Prevention said on Feb. 19 after monitoring the first month of vaccinations between December 2020 and January 2021.
AstraZeneca and Oxford University’s Covid-19 vaccine is more effective when its second dose is given three months after the first, instead of six weeks, a peer-reviewed study published in The Lancet medical journal showed on Feb. 19.
The White House is increasing the supply of coronavirus vaccines sent each week to states to 13.5 million doses, and is also doubling the amount shipped to pharmacies to 2 million doses during the week of Feb. 15.
Israel’s largest healthcare provider reported a 94% drop in symptomatic Covid-19 infections among 600,000 people who received two doses of Pfizer’s vaccine in the country’s biggest study to date.
The U.S. Centers for Disease Control and Prevention said the agency had administered 48,410,558 doses of Covid-19 vaccines in the country as of the morning of Feb. 12 and delivered 69,014,725 doses.
AstraZeneca expects to produce more than 100 million doses of the company’s Covid-19 vaccine – developed with Oxford University – during February, ramping up to more than 200 million a month by April, Chief Executive Pascal Soriot said.
Feb. 5 was a different sort of Opening Day at Yankee Stadium, the legendary home of baseball’s “Bronx Bombers,” as New York ramped up its drive to vaccinate the state’s most vulnerable residents, many who live in the hard-hit Bronx neighborhoods that surround the legendary sports venue.
AstraZeneca Plc will file for Japanese approval of the company’s Covid-19 vaccine as early as mid-February, the Yomiuri newspaper reported, marking the second vaccine maker to seek approval in Japan.
Sanofi will fill and pack millions of doses of Pfizer’s Covid-19 vaccine from July in an effort to help meet the huge demand for the U.S. drugmaker’s shots.
